Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Poor quality product administered, Product temperature excursion issue
Clinical narrative: Each patient received dose of Moderna vaccine post excursion; Each patient received dose of Moderna vaccine post excursion; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Each patient received dose of Moderna vaccine post excursion), POOR QUALITY PRODUCT ADMINISTERED (Each patient received dose of Moderna vaccine post excursion) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Each patient received dose of Moderna vaccine post excursion), POOR QUALITY PRODUCT ADMINISTERED (Each patient received dose of Moderna vaccine post excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Each patient received dose of Moderna vaccine post excursion), POOR QUALITY PRODUCT ADMINISTERED (Each patient received dose of Moderna vaccine post excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Each patient received dose of Moderna vaccine post excursion) and POOR QUALITY PRODUCT ADMINISTERED (Each patient received dose of Moderna vaccine post excursion).    No concomitant medications were reported.   This case contains information for the 1 of 19 patients reported by the reporter.  No treatment details were reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-706949, US-MODERNATX, INC.-MOD-2023-706951, US-MODERNATX, INC.-MOD-2023-706952, US-MODERNATX, INC.-MOD-2023-706953, US-MODERNATX, INC.-MOD-2023-706954, US-MODERNATX, INC.-MOD-2023-706950, US-MODERNATX, INC.-MOD-2023-706939, US-MODERNATX, INC.-MOD-2023-706964, US-MODERNATX, INC.-MOD-2023-706965, US-MODERNATX, INC.-MOD-2023-706966, US-MODERNATX, INC.-MOD-2023-706967, US-MODERNATX, INC.-MOD-2023-706968, US-MODERNATX, INC.-MOD-2023-707006, US-MODERNATX, INC.-MOD-2023-707012, US-MODERNATX, INC.-MOD-2023-707009, US-MODERNATX, INC.-MOD-2023-707010, US-MODERNATX, INC.-MOD-2023-707011, US-MODERNATX, INC.-MOD-2023-707014 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-706968:Patient 19 of 19 US-MODERNATX, INC.-MOD-2023-706939:Patient 3 of 19 US-MODERNATX, INC.-MOD-2023-706964:Patient 6 of 19 US-MODERNATX, INC.-MOD-2023-706951:Patient 7 of 19 US-MODERNATX, INC.-MOD-2023-706950:Patient 17 of 19 US-MODERNATX, INC.-MOD-2023-706949:Patient 4 of 19 US-MODERNATX, INC.-MOD-2023-706965:Patient 9 of 19 US-MODERNATX, INC.-MOD-2023-706952:Patient 10 of 19 US-MODERNATX, INC.-MOD-2023-706954:Patient 14 of 19 US-MODERNATX, INC.-MOD-2023-706967:Patient 16 of 19 US-MODERNATX, INC.-MOD-2023-706966:Patient 13 of 19 US-MODERNATX, INC.-MOD-2023-706953:Patient 11 of 19 US-MODERNATX, INC.-MOD-2023-707010:Patient 8 of 19 US-MODERNATX, INC.-MOD-2023-707009:Patient 5 of 19 US-MODERNATX, INC.-MOD-2023-707006:Patient 2 of 19 US-MODERNATX, INC.-MOD-2023-707012:Patient 15 of 19 US-MODERNATX, INC.-MOD-2023-707014:Patient 18 of 19 US-MODERNATX, INC.-MOD-2023-707011:Patient 12 of 19